- Home
- COMM vs NRIX Comparison
COMM vs NRIX Comparison
Compare COMM & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMM
- NRIX
- Stock Information
- Founded
- COMM 1976
- NRIX 2009
- Country
- COMM United States
- NRIX United States
- Employees
- COMM N/A
- NRIX N/A
- Industry
- COMM Radio And Television Broadcasting And Communications Equipment
- NRIX Biotechnology: Pharmaceutical Preparations
- Sector
- COMM Technology
- NRIX Health Care
- Exchange
- COMM Nasdaq
- NRIX Nasdaq
- Market Cap
- COMM 1.1B
- NRIX 1.1B
- IPO Year
- COMM 2013
- NRIX 2020
- Fundamental
- Price
- COMM $5.37
- NRIX $10.47
- Analyst Decision
- COMM Hold
- NRIX Strong Buy
- Analyst Count
- COMM 4
- NRIX 17
- Target Price
- COMM $3.50
- NRIX $30.82
- AVG Volume (30 Days)
- COMM 5.5M
- NRIX 1.0M
- Earning Date
- COMM 05-08-2025
- NRIX 04-14-2025
- Dividend Yield
- COMM N/A
- NRIX N/A
- EPS Growth
- COMM N/A
- NRIX N/A
- EPS
- COMM N/A
- NRIX N/A
- Revenue
- COMM $4,205,800,000.00
- NRIX $54,549,000.00
- Revenue This Year
- COMM $21.62
- NRIX N/A
- Revenue Next Year
- COMM $8.76
- NRIX $3.20
- P/E Ratio
- COMM N/A
- NRIX N/A
- Revenue Growth
- COMM N/A
- NRIX N/A
- 52 Week Low
- COMM $0.86
- NRIX $10.37
- 52 Week High
- COMM $7.19
- NRIX $29.56
- Technical
- Relative Strength Index (RSI)
- COMM 48.99
- NRIX 23.27
- Support Level
- COMM $5.05
- NRIX $12.20
- Resistance Level
- COMM $5.95
- NRIX $13.10
- Average True Range (ATR)
- COMM 0.26
- NRIX 0.82
- MACD
- COMM -0.01
- NRIX -0.10
- Stochastic Oscillator
- COMM 53.60
- NRIX 2.33
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. They have operating segments, which excludes our Home segment: Connectivity and Cable Solutions (CCS), Outdoor Wireless Networks (OWN), Networking, Intelligent Cellular and Security Solutions (NICS) and Access Network Solutions (ANS).
About NRIX Nurix Therapeutics Inc. Common stock
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.